Firgaira F A, Choo K H, Cotton R G, Danks D M
Biochem J. 1981 Jul 1;197(1):45-53. doi: 10.1042/bj1970045.
An antiserum was raised in a rabbit against highly purified human liver dihydropteridine reductase (EC 1.6.99.7). Dihydropteridine reductase from human liver, in human cultured fibroblasts and in continuous lymphoid cells all showed identical antigenic properties. The structural characteristics of the reductase from these three sources were further compared by the use of high-precision two-dimensional polyacrylamide-gel electrophoresis. The enzyme from radiolabelled fibroblasts and continuous lymphoid cells was isolated by immunoprecipitation or by affinity chromatography and compared with the purified liver enzyme. Two major polypeptide species were resolved, and polypeptides from all three sources co-migrated identically. Indirect evidence is presented indicating that one of the polypeptide species may have been derived from the other via a post-translational modification. These results support the concept that the same structural gene(s) encodes for dihydropteridine reductase in human liver, fibroblasts and lymphocytes.
用高度纯化的人肝二氢蝶啶还原酶(EC 1.6.99.7)在兔体内制备了抗血清。人肝、人培养成纤维细胞和连续淋巴细胞中的二氢蝶啶还原酶均表现出相同的抗原特性。通过使用高精度二维聚丙烯酰胺凝胶电泳进一步比较了这三种来源的还原酶的结构特征。通过免疫沉淀或亲和色谱法从放射性标记的成纤维细胞和连续淋巴细胞中分离出该酶,并与纯化的肝酶进行比较。分离出两种主要的多肽种类,并且来自所有三种来源的多肽迁移情况完全相同。提供的间接证据表明,其中一种多肽种类可能是通过翻译后修饰从另一种衍生而来的。这些结果支持了在人肝、成纤维细胞和淋巴细胞中由相同的结构基因编码二氢蝶啶还原酶的概念。